JUBLPHARMA.BOJUBLPHARMA.BOBSE
Loading
Year-over-year revenue growth rate
Latest
7.94%
↑ 351% vs avg
Percentile
P77
Within normal range
Streak
2 qtr
Consecutive growthAccelerating
Average
1.76%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 7.94% |
| Q3 2025 | 3.46% |
| Q2 2025 | -1.46% |
| Q1 2025 | 5.88% |
| Q4 2024 | 3.96% |
| Q3 2024 | 1.19% |
| Q2 2024 | -1.53% |
| Q1 2024 | 4.86% |
| Q4 2023 | -0.19% |
| Q3 2023 | 5.89% |
| Q2 2023 | -5.43% |
| Q1 2023 | 8.08% |
| Q4 2022 | -2.94% |
| Q3 2022 | 10.18% |
| Q2 2022 | -4.96% |
| Q1 2022 | 16.56% |
| Q4 2021 | -20.93% |
| Q3 2021 | 1.39% |
| Q2 2021 | 3.47% |
| Q1 2021 | -10.81% |
| Q4 2020 | -25.41% |
| Q3 2020 | 25.46% |
| Q2 2020 | 20.68% |
| Q1 2020 | -32.25% |
| Q4 2019 | 2.17% |
| Q3 2019 | 3.85% |
| Q2 2019 | -8.54% |
| Q1 2019 | 0.36% |
| Q4 2018 | 4.74% |
| Q3 2018 | 9.18% |
| Q2 2018 | -7.70% |
| Q1 2018 | 8.91% |
| Q4 2017 | 25.94% |
| Q3 2017 | 5.50% |
| Q2 2017 | -2.62% |
| Q1 2017 | 9.60% |
| Q4 2016 | 5.25% |
| Q3 2016 | -2.40% |
| Q2 2016 | -1.97% |
| Q1 2016 | 4.98% |